{"nct_id":"NCT04980872","title":"A Study of the Safety and Tolerability in Participants With PIK3CA-related Overgrowth Spectrum or Proteus Syndrome Who Are Being Treated With Miransertib (MK-7075) in Other Studies (MK-7075-006)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-02","start_date":"2021-11-02","start_date_type":"ACTUAL","primary_completion_date":"2030-02-07","primary_completion_date_type":"ESTIMATED","completion_date":"2030-02-07","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["MRK"]}